Next Generation Research Grant in Mal de Débarquement Syndrome
Next Generation Research Grant in Mal de Débarquement Syndrome supports early-career researchers studying disease mechanisms and developing treatments, better diagnosis, or prevention, with relevance to other diseases.
Browse similar grants
Funder: American Brain Foundation
Due Dates: October 8, 2026, at 5:00 PM CT (Application) | March 2027 (Anticipated announcement) | July 1, 2027 (Award start) | June 30, 2029 (Award end)
Funding Amounts: $150,000 over two years ($75,000 per year); indirect costs not supported
Summary: Supports early-career researchers investigating MdDS mechanisms or advancing treatments, diagnosis, or prevention, with potential relevance to other diseases.
Key Information: Applicants must have institutional support for at least 70% protected research time.
Description
Funded by the MdDS Foundation and administered by the American Brain Foundation, this Next Generation Research Grant supports early-career investigators studying Mal de Débarquement Syndrome (MdDS). The two-year award funds basic, preclinical, clinical, or translational research into disease mechanisms, as well as translational work specifically designed to develop treatments or improve diagnosis or prevention.
The program seeks research with potential relevance beyond MdDS, reflecting the American Brain Foundation’s Cure One, Cure Many philosophy that breakthroughs in one disease can accelerate progress in others. Priorities include scientific innovation, methodological rigor, feasible aims, clinical impact, and translational value. The foundations also emphasize diverse perspectives and study populations reflecting the full spectrum of people affected by MdDS, alongside mentorship and career development supporting research independence.
